Form D · Other
VIBLIOME THERAPEUTICS, LLC
Bozeman, MT · CIK 0001768843
Offering snapshot reported Feb 26, 2019 · SEC filing
- Reported sold
- $8M Offering amount: $16M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 13, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 26, 2019 | Initial | $8,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-333613
Source: Form D, filed Feb 26, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Farrell | Executive |
| Gary Flynn | Executive, Promoter |
| Robert Goodwin | Director, Executive, Promoter |
| Robert Jackson | Director |
| Jonathan Ramos | Executive |
| Bryan Sendrowski | Executive |
| Cameron Wheeler | Director |
Issuer details
Industry: Other (See others in industry)
Address:
533 E. Mendenhall Street
Bozeman, MT, 59715
Bozeman, MT, 59715